Table 2 The patient’s demographic and clinical datas among benign lesion and prostate cancer

Number of cases, n (%)

311 (67.2%)

152 (32.8%)

Ages (years), mean [SD]

61.5 ± 11.7

66.7 ± 5.9

0.079^a

PSA (ng/mL), median (IQR)

8.37 (6.45–11.07)

9.12 (7.05 ~ 18.34)

0.083^a

PV (mL), median (IQR)

37.65 (28.43 ~ 44.29)

34.72 (26.35 ~ 41.28)

0.425^a

PSAD (ng/mL²), median (IQR)

0.17 (0.09 ~ 0.41)

0.39 (0.16 ~ 1.08)

0.006^a

Biopsy results, n

ISUP grade 1 (ciPCa)

52

ISUP grade 2

47

ISUP grade 3

20

ISUP grade 4

23

ISUP grade 5

10

Lesion location, n (%)

0.747^b

Peripheral zone

Transition zone

137 (29.6%)

174 (37.6%)

79 (17.1%)

73 (15.7%)